Edgewise Therapeutics, Inc. (EWTX): Shares Outstanding

Annual figures by period end, from SEC filings.

106.25M
As of 2025-12-31
107.78M
As of 2026-06-30
+18.9%
3-year compound annual growth
n/m
5-year compound annual growth
2020-12-31: 1.01M2021-12-31: 49.50M2022-12-31: 63.26M2023-12-31: 70.45M2024-12-31: 94.84M2025-12-31: 106.25M106.25M
2020-12-31 Shares Outstanding (shares) 2025-12-31
Period endedShares OutstandingChange YoYSource filing
2025-12-31106.25M+12.0%2026-02-26, Balance as of period end
2024-12-3194.84M+34.6%2026-02-26, Balance as of period end
2023-12-3170.45M+11.4%2025-03-03, Balance as of period end
2022-12-3163.26M+27.8%2024-02-22, Balance as of period end
2021-12-3149.50Mn/m2023-02-23, Balance as of period end
2020-12-311.01Mn/a2022-02-24, Balance as of period end